{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:46:33Z","timestamp":1793018793302,"version":"4.5.0"},"reference-count":153,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1053\/j.semnuclmed.2020.02.007","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T16:36:31Z","timestamp":1583166991000},"page":"195-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":140,"title":["Ischemic Heart Disease: An Update"],"prefix":"10.1053","volume":"50","author":[{"given":"Rebekka Vibjerg","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Vognstoft","family":"Hjortbak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Erik","family":"B\u00f8tker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0001","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0002","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0003","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"Fihn","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0004","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1161\/CIR.0000000000000095","volume":"130","author":"Fihn","year":"2014","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0005","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0006","doi-asserted-by":"crossref","unstructured":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385:117-171.","DOI":"10.1016\/S0140-6736(14)61682-2"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0007","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","article-title":"Cardiovascular disease in Europe: Epidemiological update 2016","volume":"37","author":"Townsend","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0008","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart Disease and Stroke Statistics-2018 Update: A report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0009","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/eurheartj\/eht529","article-title":"Reperfusion therapy for ST elevation acute myocardial infarction 2010\/2011: Current status in 37 ESC countries","volume":"35","author":"Kristensen","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0010","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.jacc.2014.08.037","article-title":"Short- and long-term cause of death in patients treated with primary PCI for STEMI","volume":"64","author":"Pedersen","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0011","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM197906143002402","article-title":"Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease","volume":"300","author":"Diamond","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0012","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/eurheartj\/ehr014","article-title":"A clinical prediction rule for the diagnosis of coronary artery disease: Validation, updating, and extension","volume":"32","author":"Genders","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0013","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1161\/CIRCULATIONAHA.111.039255","volume":"124","author":"Cheng","year":"2011","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0014","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ehjci\/jey182","article-title":"Pretest probability for patients with suspected obstructive coronary artery disease: Re-evaluating Diamond-Forrester for the contemporary era and clinical implications: Insights from the PROMISE trial","volume":"20","author":"Foldyna","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0015","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/eurheartj\/ehy806","article-title":"Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable angina","volume":"40","author":"Reeh","year":"2019","journal-title":"Eur Heart J"},{"issue":"8 Suppl","key":"10.1053\/j.semnuclmed.2020.02.007_bib0016","doi-asserted-by":"crossref","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","article-title":"Pathogenesis of atherosclerosis","volume":"47","author":"Falk","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"2 Pt 1","key":"10.1053\/j.semnuclmed.2020.02.007_bib0017","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0735-1097(83)80093-X","article-title":"A clinically relevant classification of chest discomfort","volume":"1","author":"Diamond","year":"1983","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0018","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/circ.54.3.947585","article-title":"Letter: Grading of angina pectoris","volume":"54","author":"Campeau","year":"1976","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0019","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0020","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: A report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0021","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0022","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/MCA.0b013e3282f27c0a","article-title":"Association of anemia with clinical outcomes in stable coronary artery disease","volume":"19","author":"da Silveira","year":"2008","journal-title":"Coron Artery Dis"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0023","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1371\/journal.pmed.0040270","article-title":"Renal function and risk of coronary heart disease in general populations: New prospective study and systematic review","volume":"4","author":"Di","year":"2007","journal-title":"PLoS Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0024","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus creatinine in determining risk based on kidney function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0025","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: A systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0026","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/hrt.2005.086975","article-title":"Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: A report from the Euro Heart Survey on Diabetes and the Heart","volume":"93","author":"Bartnik","year":"2007","journal-title":"Heart"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0027","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0028","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.jacc.2007.08.005","article-title":"Transient ST-segment depression during paroxysms of atrial fibrillation in otherwise normal individuals: Relation with underlying coronary artery disease","volume":"50","author":"Androulakis","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0029","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.CIR.0000088001.59265.EE","article-title":"Silent myocardial ischemia","volume":"108","author":"Cohn","year":"2003","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/CIA.S21775","article-title":"Medical treatment and long-term outcome of chronic atrial fibrillation in the aged with chest distress: A retrospective analysis versus sinus rhythm","volume":"6","author":"Guo","year":"2011","journal-title":"Clin Interv Aging"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0031","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s10554-010-9725-x","article-title":"Relationship between obstructive coronary artery disease and abnormal stress testing in patients with paroxysmal or persistent atrial fibrillation","volume":"27","author":"Nucifora","year":"2011","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0032","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0195-668X(02)00820-5","article-title":"The value of routine non-invasive tests to predict clinical outcome in stable angina","volume":"24","author":"Daly","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0033","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/CIRCIMAGING.113.000989","article-title":"Myocardial strain analysis by 2-dimensional speckle tracking echocardiography improves diagnostics of coronary artery stenosis in stable angina pectoris","volume":"7","author":"Biering-Sorensen","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0034","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jacc.2012.06.022","article-title":"Duration of myocardial early systolic lengthening predicts the presence of significant coronary artery disease","volume":"60","author":"Smedsrud","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0035","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s10554-015-0646-6","article-title":"Sensitive cardiac troponins and N-terminal pro-B-type natriuretic peptide in stable coronary artery disease: Correlation with left ventricular function as assessed by myocardial strain","volume":"31","author":"Smedsrud","year":"2015","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0036","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0037","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/jex182","article-title":"Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017","volume":"18","author":"Senior","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0038","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jama.2016.12680","article-title":"Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion scintigraphy, or NICE guidelines on subsequent unnecessary angiography rates: The CE-MARC2 randomized clinical trial","volume":"316","author":"Greenwood","year":"2016","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0039","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jcct.2016.10.002","article-title":"SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: A report of the society of Cardiovascular Computed Tomography Guidelines Committee: Endorsed by the North American Society for Cardiovascular Imaging (NASCI)","volume":"10","author":"Abbara","year":"2016","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0040","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.amjcard.2012.10.029","article-title":"Diagnostic performance of computed tomography coronary angiography (from the Prospective National Multicenter Multivendor EVASCAN Study)","volume":"111","author":"Gueret","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0041","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jcmg.2015.06.003","article-title":"Influence of coronary calcification on the diagnostic performance of CT angiography derived FFR in coronary artery disease: A substudy of the NXT trial","volume":"8","author":"Norgaard","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0042","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00330-015-3831-z","article-title":"Diagnostic accuracy and utility of coronary CT angiography with consideration of unevaluable results: A systematic review and multivariate Bayesian random-effects meta-analysis with intention to diagnose","volume":"26","author":"Menke","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0043","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/jamacardio.2017.2471","article-title":"Comparison of coronary CT angiography, SPECT, PET, and hybrid imaging for diagnosis of ischemic heart disease determined by fractional flow reserve","volume":"2","author":"Danad","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0044","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jcmg.2008.11.015","article-title":"Prognostic value of coronary computed tomographic angiography for prediction of cardiac events in patients with suspected coronary artery disease","volume":"2","author":"Hadamitzky","year":"2009","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0045","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2011.02.074","volume":"58","author":"Min","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0046","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/eurheartj\/ehv700","article-title":"Calcium imaging and selective computed tomography angiography in comparison to functional testing for suspected coronary artery disease: The multicentre, randomized CRESCENT trial","volume":"37","author":"Lubbers","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0047","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1805971","article-title":"Coronary CT angiography and 5-year risk of myocardial infarction","volume":"379","author":"Newby","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0048","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0140-6736(15)60291-4","article-title":"CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0049","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1415516","article-title":"Outcomes of anatomical versus functional testing for coronary artery disease","volume":"372","author":"Douglas","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0050","doi-asserted-by":"crossref","first-page":"k504","DOI":"10.1136\/bmj.k504","article-title":"Outcomes of non-invasive diagnostic modalities for the detection of coronary artery disease: Network meta-analysis of diagnostic randomised controlled trials","volume":"360","author":"Siontis","year":"2018","journal-title":"BMJ"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0051","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcard.2018.09.094","article-title":"General practice preventive health care in non-obstructive coronary artery disease determined by coronary computed tomography angiography","volume":"278","author":"Mols","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0052","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/ATVBAHA.114.304351","volume":"35","author":"Chow","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0053","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1001\/jamainternmed.2017.4772","article-title":"Coronary computed tomography angiography vs functional stress testing for patients with suspected coronary artery disease: A systematic review and meta-analysis","volume":"177","author":"Foy","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0054","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.jacc.2012.11.083","article-title":"Computational fluid dynamics applied to cardiac computed tomography for noninvasive quantification of fractional flow reserve: Scientific basis","volume":"61","author":"Taylor","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0055","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.jacc.2011.06.066","volume":"58","author":"Koo","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0056","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jacc.2013.11.043","article-title":"Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps)","volume":"63","author":"Norgaard","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0057","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jacc.2016.05.057","article-title":"1-year outcomes of FFRCT-guided care in patients with suspected coronary disease: The PLATFORM study","volume":"68","author":"Douglas","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0058","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.jacc.2018.07.043","article-title":"Coronary CT angiographic and flow reserve-guided management of patients with stable ischemic heart disease","volume":"72","author":"Norgaard","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0059","first-page":"3689","article-title":"Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease","volume":"39","author":"Collet","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0060","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1016\/j.jacc.2018.02.053","article-title":"Fractional flow reserve derived from computed tomographic angiography in patients with multivessel CAD","volume":"71","author":"Collet","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0061","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/CIRCULATIONAHA.114.011939","article-title":"Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization","volume":"131","author":"Taqueti","year":"2015","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0062","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1093\/eurheartj\/ehy267","article-title":"The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability","volume":"39","author":"Knuuti","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0063","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jacc.2012.09.043","article-title":"Prognostic value of stress myocardial perfusion positron emission tomography: Results from a multicenter observational registry","volume":"61","author":"Dorbala","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0064","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/ehjci\/jex014","article-title":"Comparison of the prognostic value of negative non-invasive cardiac investigations in patients with suspected or known coronary artery disease-a meta-analysis","volume":"18","author":"Smulders","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0065","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10554-007-9215-y","article-title":"Myocardial viability by contrast-enhanced cardiovascular magnetic resonance in patients with coronary artery disease: Comparison with gated single-photon emission tomography and FDG position emission tomography","volume":"23","author":"Wu","year":"2007","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0066","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jcmg.2018.05.007","article-title":"Comparing cardiac magnetic resonance-guided versus angiography-guided treatment of patients with stable coronary artery disease: results from a prospective randomized controlled trial","volume":"11","author":"Buckert","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0067","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/CIRCIMAGING.113.000035","article-title":"The prognostic value of normal stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a meta-analysis","volume":"6","author":"Gargiulo","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0068","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jacc.2013.03.080","article-title":"Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: A systematic review and meta-analysis","volume":"62","author":"Lipinski","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0069","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJM200011163432003","article-title":"The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction","volume":"343","author":"Kim","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0070","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s11897-018-0396-6","article-title":"Identifying and managing hibernating myocardium: What's new and what remains unknown?","volume":"15","author":"Ryan","year":"2018","journal-title":"Curr Heart Fail Rep"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0071","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10534-016-9931-7","article-title":"Gadolinium-based contrast agent toxicity: A review of known and proposed mechanisms","volume":"29","author":"Rogosnitzky","year":"2016","journal-title":"Biometals"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0072","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1056\/NEJM199606273342604","article-title":"Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses","volume":"334","author":"Pijls","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0073","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1161\/01.CIR.92.11.3183","article-title":"Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow","volume":"92","author":"Pijls","year":"1995","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0074","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1093\/eurheartj\/ehu094","article-title":"Evolving concepts of angiogram: Fractional flow reserve discordances in 4000 coronary stenoses","volume":"35","author":"Toth","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0075","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/eurheartj\/ehv711","article-title":"Mechanisms of stent thrombosis analysed by optical coherence tomography: Insights from the national PESTO French registry","volume":"37","author":"Souteyrand","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0076","doi-asserted-by":"crossref","unstructured":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.","DOI":"10.1136\/bmj.324.7329.71"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0077","doi-asserted-by":"crossref","unstructured":"Collaborative overview of randomised trials of antiplatelet therapy\u2013I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 1994;308:81-106.","DOI":"10.1136\/bmj.308.6921.81"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0078","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0079","doi-asserted-by":"crossref","unstructured":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet1996;348:1329-1339.","DOI":"10.1016\/S0140-6736(96)09457-3"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0080","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.jacc.2014.09.008","article-title":"Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: The SECURITY randomized clinical trial","volume":"64","author":"Colombo","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0081","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002524","article-title":"Incremental value of the CRUSADE, ACUITY, and HAS-BLED risk scores for the prediction of hemorrhagic events after coronary stent implantation in patients undergoing long or short duration of dual antiplatelet therapy","volume":"4","author":"Costa","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0082","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacc.2014.11.008","article-title":"6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial","volume":"65","author":"Gilard","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0083","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.111.059022","article-title":"Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study","volume":"125","author":"Gwon","year":"2012","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0084","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/eurheartj\/ehu523","article-title":"ISAR-SAFE: A randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting","volume":"36","author":"Schulz-Schupke","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0085","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.111.071589","article-title":"Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial","volume":"125","author":"Valgimigli","year":"2012","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0086","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jacc.2015.01.039","article-title":"Duration of dual antiplatelet therapy after drug-eluting stent implantation: A systematic review and meta-analysis of randomized controlled trials","volume":"65","author":"Giustino","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0087","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h1618","article-title":"Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: Meta-analysis of randomised controlled trials","author":"Navarese","year":"2015","journal-title":"BMJ"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0088","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/S0140-6736(15)60263-X","article-title":"Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: A pairwise and Bayesian network meta-analysis of randomised trials","volume":"385","author":"Palmerini","year":"2015","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0089","first-page":"2510","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: The OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0090","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0091","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJMoa1205512","article-title":"Prasugrel versus clopidogrel for acute coronary syndromes without revascularization","volume":"367","author":"Roe","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0092","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0093","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0094","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","author":"Mega","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0096","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jacc.2015.02.050","article-title":"Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: The ISAR-TRIPLE trial","volume":"65","author":"Fiedler","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0097","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0098","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","article-title":"Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR\/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group","volume":"283","author":"Hjalmarson","year":"2000","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0099","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.2012.12559","article-title":"Beta-blocker use and clinical outcomes in stable outpatients with and without coronary artery disease","volume":"308","author":"Bangalore","year":"2012","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0100","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jcin.2016.05.048","article-title":"Predictors, trends, and outcomes (among older patients >\/=65 years of age) associated with beta-blocker use in patients with stable angina undergoing elective percutaneous coronary intervention: Insights from the NCDR registry","volume":"9","author":"Motivala","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0101","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40265-017-0691-7","article-title":"Drug therapy for stable angina pectoris","volume":"77","author":"Rousan","year":"2017","journal-title":"Drugs"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0102","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00019501-200212000-00008","article-title":"Efficacy of monotherapy compared with combined antianginal drugs in the treatment of chronic stable angina pectoris: A meta-analysis","volume":"13","author":"Klein","year":"2002","journal-title":"Coronary Artery Dis"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0103","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1177\/2047487314533217","article-title":"Relative efficacy of antianginal drugs used as add-on therapy in patients with stable angina: A systematic review and meta-analysis","volume":"22","author":"Belsey","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0104","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/eurheartj\/ehn571","article-title":"Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: A 4-month, randomized, placebo-controlled trial","volume":"30","author":"Tardif","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/ehjcvp\/pvu020","article-title":"Pharmacotherapy for coronary microvascular dysfunction","volume":"1","author":"Ong","year":"2015","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0106","doi-asserted-by":"crossref","unstructured":"Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013). Circ J2014;78:2779-2801.","DOI":"10.1253\/circj.CJ-66-0098"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0107","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0108","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0109","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0110","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0111","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0112","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/CIRCULATIONAHA.109.891523","article-title":"Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes","volume":"121","author":"Chow","year":"2010","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0113","article-title":"Smoking cessation for the secondary prevention of coronary heart disease","author":"Critchley","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0114","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/jama.290.1.86","article-title":"Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review","volume":"290","author":"Critchley","year":"2003","journal-title":"JAMA"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0115","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.jacc.2014.07.973","article-title":"Prognostic value of fractional flow reserve: Linking physiologic severity to clinical outcomes","volume":"64","author":"Johnson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0116","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0117","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.amjcard.2015.01.556","article-title":"Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia","volume":"115","author":"Gada","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0118","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1161\/01.CIR.0000072790.23090.41","article-title":"Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography","volume":"107","author":"Hachamovitch","year":"2003","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0119","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/CIRCULATIONAHA.107.743963","article-title":"Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy","volume":"117","author":"Shaw","year":"2008","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0120","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jcmg.2013.10.021","article-title":"Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging","volume":"7","author":"Shaw","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0121","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jacc.2011.11.003","article-title":"Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study","volume":"59","author":"Sen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0122","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1700445","article-title":"Use of the instantaneous wave-free ratio or fractional flow reserve in PCI","volume":"376","author":"Davies","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0123","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1616540","article-title":"Instantaneous wave-free ratio versus fractional flow reserve to guide PCI","volume":"376","author":"Gotberg","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0124","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(15)60648-1","article-title":"Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial","volume":"386","author":"Engstrom","year":"2015","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0125","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJMoa1701067","article-title":"Fractional flow reserve-guided multivessel angioplasty in myocardial infarction","volume":"376","author":"Smits","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0126","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1803538","article-title":"Five-year outcomes with PCI guided by fractional flow reserve","volume":"379","author":"Xaplanteris","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0127","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/eurheartj\/ehy812","article-title":"Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data","volume":"40","author":"Zimmermann","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0128","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0129","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1056\/NEJMoa1408758","article-title":"Fractional flow reserve-guided PCI for stable coronary artery disease","volume":"371","author":"De","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0130","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.115.018747","article-title":"Significance of intermediate values of fractional flow reserve in patients with coronary artery disease","volume":"133","author":"Adjedj","year":"2016","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0131","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1161\/CIRCULATIONAHA.116.024433","article-title":"Fractional flow reserve and cardiac events in coronary artery disease: Data from a prospective IRIS-FFR registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve)","volume":"135","author":"Ahn","year":"2017","journal-title":"Circulation"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0132","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jacc.2007.01.087","article-title":"Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study","volume":"49","author":"Pijls","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0133","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jcin.2012.10.014","article-title":"Fractional flow reserve-guided revascularization: practical implications of a diagnostic gray zone and measurement variability on clinical decisions","volume":"6","author":"Petraco","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0134","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jcin.2015.01.029","article-title":"Prospective assessment of the diagnostic accuracy of instantaneous wave-free ratio to assess coronary stenosis relevance: Results of ADVISE II international, multicenter study (ADenosine Vasodilator Independent Stenosis Evaluation II)","volume":"8","author":"Escaned","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0135","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJMoa1415447","article-title":"Trial of everolimus-eluting stents or bypass surgery for coronary disease","volume":"372","author":"Park","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0136","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/S0140-6736(16)32052-9","article-title":"Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): A prospective, randomised, open-label, non-inferiority trial","volume":"388","author":"Makikallio","year":"2016","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0137","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1100452","article-title":"Randomized trial of stents versus bypass surgery for left main coronary artery disease","volume":"364","author":"Park","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0138","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1056\/NEJMoa1610227","article-title":"Everolimus-eluting stents or bypass surgery for left main coronary artery disease","volume":"375","author":"Stone","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0139","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jcin.2017.04.037","article-title":"Comparison of stenting versus bypass surgery according to the completeness of revascularization in severe coronary artery disease: Patient-level pooled analysis of the SYNTAX, PRECOMBAT, and BEST trials","volume":"10","author":"Ahn","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0140","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(18)30423-9","article-title":"Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data","volume":"391","author":"Head","year":"2018","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0141","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial","volume":"381","author":"Mohr","year":"2013","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0142","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0143","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.jacc.2007.09.006","article-title":"F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2)","volume":"50","author":"Beanlands","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0144","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa1100358","article-title":"Myocardial viability and survival in ischemic left ventricular dysfunction","volume":"364","author":"Bonow","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0195-668X(02)00468-2","article-title":"Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial\u2013PRAGUE-2","volume":"24","author":"Widimsky","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0146","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa025142","article-title":"A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction","volume":"349","author":"Andersen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0147","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0148","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurheartj\/ehz595","article-title":"16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: Primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction","volume":"41","author":"Thrane","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0149","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jcin.2016.11.047","article-title":"Complete or culprit-only revascularization for patients with multivessel coronary artery disease undergoing percutaneous coronary intervention: A pairwise and network meta-analysis of randomized trials","volume":"10","author":"Elgendy","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0150","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jacc.2014.12.038","article-title":"Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: The CvLPRIT trial","volume":"65","author":"Gershlick","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0151","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJMoa1907775","article-title":"Complete revascularization with multivessel PCI for myocardial infarction","volume":"381","author":"Mehta","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0152","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJMoa1305520","article-title":"Randomized trial of preventive angioplasty in myocardial infarction","volume":"369","author":"Wald","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2020.02.007_bib0153","first-page":"219","article-title":"The SYNTAX Score: An angiographic tool grading the complexity of coronary artery disease","volume":"1","author":"Sianos","year":"2005","journal-title":"EuroIntervention"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299820300088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299820300088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:36:18Z","timestamp":1757543778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299820300088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":153,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0001299820300088"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2020.02.007","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ischemic Heart Disease: An Update","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2020.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}